Regorafenib A Kinase inhibitor
24/01/2022 Alternative Treatments
Price: Check with seller
Description
The medicine Regorafenib is a kinase inhibitor that healthcare professionals recommend for the treatment of metastatic colorectal cancer (CRC) who have been previously treated with fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapy, an anti-VEGF therapy, and, if KRAS wild type, an anti-EGFR therapy. This medicine is available in the strength of 40 mg as tablets for oral administration. The active ingredient in the medicine is Regorafenib monohydrate, and the inactive ingredients are cellulose microcrystalline, croscarmellose sodium, magnesium stearate, povidone, and colloidal silicon dioxide.
Regorafenib 40 mg is readily available in India at a reasonable price, and one can easily buy this medicine from any generic medicine supplier.
Comments
More Details